Summary: GLP-1 receptor agonists do not directly cause sweating, but some patients report changes in perspiration patterns due to indirect factors such as gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or autonomic responses to nausea
But for Type 2 diabetes, the approved starting dose is 0.25 milligrams (mg) weekly
In most cases, staying on semaglutide during a plateau is still considered safe, as long as your provider is monitoring you
Dehydration Because Wegovy can cause gastrointestinal side effects such as nausea, vomiting, or diarrhea, these symptoms may lead to dehydration, which can, in turn, result in dizziness
Apex guarantees that you will receive personalized care with a comprehensive approach, explains Stebbins